+73.1%
CDNS vs MRNA
-69.5%
+142.6%
-31.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | +0.7% | -0.6% | +0.1% |
| 7D | -6.5% | -8.2% | +1.7% | -6.1% |
| 30D | -13.0% | +125.6% | -138.6% | -21.5% |
| 3M | -26.0% | +197.1% | -223.1% | -36.5% |
| 6M | -2.8% | +148.5% | -151.3% | -14.6% |
| YTD | -8.8% | +363.3% | -372.1% | -27.6% |
| 1Y | -15.8% | +462.0% | -477.8% | -35.8% |
| 3Y | +19.7% | +26.9% | -7.2% | +7.9% |
| All | +73.1% | -69.5% | +142.6% | +70.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling